Biomarkers of response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Clara J. Oh, Kieran Sweeney, Andrew Elliott, George W. Sledge, Vaia Florou, Moh'd M. Khushman, Emil Lou, Rachna T. Shroff, Marcus Smith Noel, Brandon Huffman, Harshabad Singh, Erkut H. Borazanci, Gretel Terrero, Nipun B. Merchant, Piyush Kumar Sharma, Anna Bianchi, Ramiro Verdun, Luis Nivelo, Jashodeep Datta, Peter Joel Hosein
Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Caris Life Sciences (United States), Huntsman Cancer Institute, Washington University in St. Louis, University of Minnesota, University of Arizona Cancer Center, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Dana-Farber Cancer Institute, HonorHealth
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410817196